Mold-Tek Packaging's pharma scale-up and EBITDA per kg expansion support growth

Investment Thesis

In its August 29, 2026 Pick of the Week report, Axis Securities identifies Mold-Tek Packaging Ltd as a high-conviction packaging idea. The thesis is supported by healthy growth in core categories, the scale-up of high-margin pharmaceutical packaging, product innovation and capacity additions.

Mold-Tek Packaging is a rigid plastic packaging manufacturer and a pioneer in In-Mold Labelling technology. It supplies customised packaging to paints, lubricants, food and FMCG, and pharmaceutical customers, supported by in-house mould-making, robotics capabilities and plant consolidation.

Structural Margin Expansion

The principal operating positive is structural margin expansion. Mold-Tek Packaging reported its highest-ever EBITDA per kg of Rs 46.7 in Q1 FY27. Axis Securities attributes this improvement to higher capacity utilisation, consolidation of the Hyderabad plants and a richer product mix.

Management raised FY27 EBITDA per kg guidance to Rs 44-45 from Rs 42-43 previously. The broker interprets the revised guidance as confidence that the cost savings are durable.

The consolidation of five Hyderabad facilities into two integrated manufacturing units has reduced inter-unit transport, logistics bottlenecks, printing wastage and fixed administrative overheads, supporting sustained operating efficiency.

Pharmaceutical Packaging and Core Business Growth

Pharmaceutical packaging is a key long-term earnings-quality driver in the broker's thesis. The division recorded 39 per cent volume growth in Q1 FY27 and represented about 3.5 per cent of total sales. Management aims to scale pharmaceutical segment revenue to Rs 50-55 crore by the end of FY27.

The strategy is to move beyond basic packaging towards higher-margin diagnostic kits, ophthalmic products, dosage pens and medical devices. Axis Securities expects this mix improvement to support further expansion in EBITDA per kg.

Core businesses also retained momentum in Q1 FY27. Paints volumes rose 11 per cent, with sales of Rs 139 crore, while Food and FMCG volumes increased 26 per cent year-on-year, with sales of Rs 66 crore. Lubricants and Q-Pack experienced short-term weakness because of temporary raw-material disruptions. Management expects recovery from Q2 FY27, supporting its FY27 volume-growth objective of 10-12 per cent.

Growth Outlook and Financial Estimates

Axis Securities expects multi-year growth to be supported by capacity additions, onboarding of new customers, operating leverage and a rising pharmaceutical mix. The broker's financial estimates are as follows:

Valuation and Recommendation

Axis Securities values Mold-Tek Packaging at 19 times FY28E EPS and recommends BUY, with a target price of Rs 760 per share. This implies around 10 per cent upside from the reported CMP of Rs 691. The stated investment horizon is six to nine months.

Key Operating Concern and Report Limitations

The temporary raw-material disruption affecting Lubricants and Q-Pack is the principal operating concern highlighted in the report. Management expects these businesses to recover from Q2 FY27.

The report does not provide a formal list of additional risks or a comparison of reported Q1 FY27 results with broker or consensus estimates.